Amneal Pharmaceuticals, Inc. - News - Press Releases

2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002

Jan 14, 2019

Amneal Announces Approval of Rivastigmine Transdermal System

Jan 04, 2019

Amneal Names David A. Buchen Senior Vice President, Chief Legal Officer And Corporate Secretary

© Amneal Pharmaceuticals LLC.

All rights reserved.

Powered By Q4 Inc. 5.15.0.14